Adoption of PD as the main surgical approach is not associated with survival disadvantage...
Raleigh, NC (PRWEB) December 05, 2015
Scientists in Turkey have found no significant difference in survival outcomes between mesothelioma patients who underwent lung-sparing surgery and those who had the more radical lung-removing approach. Surviving Mesothelioma has just posted news of the new study and reaction to it on the website. Click here to read the full article.
The researchers compared the cases of 72 mesothelioma patients who underwent lung-removing extrapleural pneumonectomy or lung-sparing pleurectomy and decortication (PD). The differences between the two groups were negligible.
“Adoption of PD as the main surgical approach is not associated with survival disadvantage in the surgical treatment of malignant pleural mesothelioma,” concludes author and researcher Hasan Fevzi Batirel, MD, PhD.
Dr. Batirel’s research appears in the Journal of Thoracic and Cardiovascular Surgery.
“While the latest study appears to favor a more conservative approach to mesothelioma surgery, the decision still comes down to mesothelioma patients and their doctors,” says Alex Strauss, Managing Editor of Surviving Mesothelioma. “We hope to help make that decision a little easier by providing our readers with the very latest scientific evidence.”
To read more about the Turkish study, the response of one of the nation’s top mesothelioma surgeons, and the different approaches to mesothelioma surgery, see The Mesothelioma Surgery Debate: Is it Over?, now available on the Surviving Mesothelioma website.
Batirel, H.F., et al,. Adoption of pleurectomy and decortication for malignant mesothelioma leads to similar survival as extrapleural pneumonectomy. J Thorac Cardiovasc Surg. October 9, 2015; Epub ahead of print, http://www.ncbi.nlm.nih.gov/pubmed/26611742